| | Croatia | Egypt | Georgia | Iran | Serbia | Turkey | Ukraine |
| Main reservoir(s) | Fox | Dog | Dog, jackal, wolf | Dog, wolf, fox, jackal | Fox | Dog, fox, jackal | Dog, fox |
| Main vector(s) | Dog, cat | Dog | Dog, cat | Dog | Dog, cat | Dog | Cat, dog |
| Human population (estimates)* | ~4,500,000 | ~80,500,000 | ~4,600,000 | ~76,900,000 | ~7,300,000 | ~77,800,000 | ~45,500,000 |
| Number of human rabies cases reported between 2000–2009 [1999–2009 for Turkey] | 0 | 880 | 90 | 62 | 0 | 21 | 29 |
| Human rabies cases reported in 2009** | 0 | 80 | 6 | 2 | 0 | 2 | 6 |
| Estimated human rabies incidence per million (2009)** | — | 0.99 | 1.30 | 0.02 | — | 0.025 | 0.13 |
| Number of PEP (2009) | 1,750 | ~200,000 | 28,055 | 130,531 | 1,609 | 178,250 | 21,000 |
| PEP incidence per million people (2009)** | 388 | ~2,485 | 6,100 | 1,700 | 220 | 2,290 | 461 |
| PEP vaccination regimen | 4 doses IM (Zagreb 2-1-1) Rarely: 5 doses IM (Essen) | 6 doses IM at days 0, 3, 7, 14, 28, 90 | 6 doses IM at days 0, 3, 7, 14, 28, 90 | 5 doses IM at days 0, 3, 7, 14, 28 | 5 doses IM at days 0, 3, 7, 14, 28 | 5 doses IM at days 0, 3, 7, 14, and 21 or 28 | 6 doses IM at days 0, 3, 7, 14, 28, 90 |
| Type of rabies Immunoglobulin used | HRIG (locally produced) | HRIG (private sector) | ERIG (public sector) HRIG (private sector) | HRIG (public sector) | HRIG (locally produced) | ERIG (public sector) HRIG (private sector) | ERIG (locally produced) |
| Number of PrEP in 2009 | 200 (population at risk) | N.a.*** | Vets (on a voluntary basis) | N.a. (population at risk) | 51 (population at risk) | 991 (population at risk) | N.a. (population at risk) |
|
|